Feed / MD

Pediatrix Medical Group, Inc.

MD

Healthcare · 26.39 +1.2% today

Partial group confirmationMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

Pediatrix Medical Group, Inc.'s move is being confirmed by its market group.

MD accounts for 37.5% of the group's measured movement across 2.9 effective names. all 3 measured members are falling in raw terms, but 2 of 3 session-normalized paths align to the downside. Capital-flow agreement is 25%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveDominant mover#2 of 3 by movement share
Group movement share37.5%Absolute path energy—not portfolio weight
Relative path+1.62%counter
Effective breadth2.9 / 3balanced
Relative alignment2/3downside path · 1 counter-moving
Capital-flow agreement25%not yet clean
SEQUENCE READ

TCMD moved materially before MD. MD crossed its material path threshold at 10:05 ET. FJIKY followed.

EVIDENCE COVERAGE

3 of 3 members in Healthcare Conglomerates are active. 0 of 4 disclosed connections are confirming.

What would change this read
  • At least 2 of 3 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as CNC begins moving with the group.

Invalidation: The live read weakens if participation falls to 1 of 3 members or fewer.

Watch this read

Who this business touches

The relationships behind MD

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

JPMJP Morgan Chase & Co.lenderMay 5, 2026 ▾

“The Credit Agreement, as amended by the Credit Agreement Amendment (the “Amended Credit Agreement”), among other things, (i) refinanced the prior unsecured revolving credit facility with a $450.0 million unsecured revolving credit facility, including a $37.5…”

Depended on by

SPRYARS Pharmaceuticals, Inc.partnerMay 15, 2026 ▾

“In December 2025, we received approval in China of 优敏速 (the trade name for neffy 2 mg in China), with commercial launch by our collaboration partner, Pediatrix, expected to start in the first half of 2026.”

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

MD is currently a Early Follower in the organic co-movement group Healthcare Conglomerates. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.